Stocks · News reference
Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Alight, Inc. / Delaware (ALIT)
Filed: 2026-10-14 AccNo: 0001628280-26-065893 Size: 152 KB Item 7.01: Regulation FD Disclosure
Alight Announces Acquisition Of Benefits Data Technology Company Abett; Terms Not Disclosed
Alight shares are trading lower after DA Davidson lowered its price target on the stock from $32 to $22.
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $260
Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises the price target from $250 to $260.
8-K filing — QUEST DIAGNOSTICS INC (DGX)
Filed: 2026-10-06 AccNo: 0000947871-26-000922 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers